Literature DB >> 28824738

Breast cancer and Flammer syndrome: any symptoms in common for prediction, prevention and personalised medical approach?

Pavol Zubor1,2, Alexandra Gondova1, Jiri Polivka3,4, Petra Kasajova1, Katarzyna Konieczka5, Jan Danko1, Olga Golubnitschaja6,7,8.   

Abstract

An epidemic scale of the breast cancer (BC) prevalence is actually recognised as the reality of the early twenty-first century. Particularly alarming is that the sporadic BC (about 90% of all patients) creates currently unpredictable subpopulations in terms of disease predisposition, development and progression. Despite broad discussions run since years in BC area, no any plausible approach has been suggested so far to get the overall situation better controlled in the populations. Here, we present highly innovative concepts considering investigation of specific syndromes and symptoms underestimated till now in relationship with BC predisposition and development. Consequently, the purpose of our pilot project was to evaluate the prevalence of Flammer Syndrome (FS) in BC patient cohort. The results achieved here support the main hypothesis of the project clearly demonstrating the tendency of BC patients to the increased prevalence of FS symptoms compared to the disease-free individuals. Our study strongly indicates the relevance of FS symptoms for BC pathology such as feeling inadequately cold, deficient thermoregulation, altered sensitivity to different stimuli, potential dehydration, altered sleep patterns, tendency towards headache, migraine attacks and dizziness. Moreover, the symptoms' appearance is specifically linked to the individual BC subtypes. Potential mechanisms interconnecting FS with BC pathology are discussed.

Entities:  

Keywords:  Breast cancer; Cardiovascular component; Drug sensitivity; Flammer syndrome; Pain; Patient stratification; Predictive preventive personalised medicine; Sense regulation; Systemic hypoxia; Thermoregulation

Year:  2017        PMID: 28824738      PMCID: PMC5545996          DOI: 10.1007/s13167-017-0089-3

Source DB:  PubMed          Journal:  EPMA J        ISSN: 1878-5077            Impact factor:   6.543


  27 in total

Review 1.  Mapping oxidative changes in breast cancer: understanding the basic to reach the clinics.

Authors:  Andre Mencalha; Vanessa Jacob Victorino; Rubens Cecchini; Carolina Panis
Journal:  Anticancer Res       Date:  2014-03       Impact factor: 2.480

2.  Frequency of symptoms and signs of primary vascular dysregulation in Swiss and Korean populations.

Authors:  K Konieczka; H J Choi; S Koch; A Schoetzau; D Küenzi; D M Kim
Journal:  Klin Monbl Augenheilkd       Date:  2014-04-25       Impact factor: 0.700

3.  Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up.

Authors:  C W Elston; I O Ellis
Journal:  Histopathology       Date:  1991-11       Impact factor: 5.087

4.  Increased Prevalence of Flammer Syndrome in Patients with Retinitis Pigmentosa.

Authors:  K Konieczka; S Koch; A Schoetzau; M G Todorova
Journal:  Klin Monbl Augenheilkd       Date:  2016-04-26       Impact factor: 0.700

5.  Risk assessment, disease prevention and personalised treatments in breast cancer: is clinically qualified integrative approach in the horizon?

Authors:  Olga Golubnitschaja; Kristina Yeghiazaryan; Vincenzo Costigliola; Daniela Trog; Michael Braun; Manuel Debald; Walther Kuhn; Hans H Schild
Journal:  EPMA J       Date:  2013-02-19       Impact factor: 6.543

6.  The effect of flammer-syndrome on retinal venous pressure.

Authors:  Lei Fang; Michael Baertschi; Maneli Mozaffarieh
Journal:  BMC Ophthalmol       Date:  2014-10-13       Impact factor: 2.209

7.  Dissecting the Origin of Breast Cancer Subtype Stem Cell and the Potential Mechanism of Malignant Transformation.

Authors:  Xinyi Liu; Dongfei Feng; Dianming Liu; Shuyuan Wang; Xuexin Yu; Enyu Dai; Jing Wang; Lihong Wang; Wei Jiang
Journal:  PLoS One       Date:  2016-10-21       Impact factor: 3.240

8.  Vasospastic individuals demonstrate significant similarity to glaucoma patients as revealed by gene expression profiling in circulating leukocytes.

Authors:  Kristina Yeghiazaryan; Josef Flammer; Selim Orgül; Kerstin Wunderlich; Olga Golubnitschaja
Journal:  Mol Vis       Date:  2009-11-14       Impact factor: 2.367

9.  Key molecular pathways affected by glaucoma pathology: is predictive diagnosis possible?

Authors:  Olga Golubnitschaja; Kristina Yeghiazaryan; Josef Flammer
Journal:  EPMA J       Date:  2010-06-29       Impact factor: 6.543

Review 10.  Retinal venous pressure: the role of endothelin.

Authors:  Josef Flammer; Katarzyna Konieczka
Journal:  EPMA J       Date:  2015-10-26       Impact factor: 6.543

View more
  17 in total

Review 1.  Plant natural modulators in breast cancer prevention: status quo and future perspectives reinforced by predictive, preventive, and personalized medical approach.

Authors:  Sona Uramova; Peter Kubatka; Zuzana Dankova; Andrea Kapinova; Barbora Zolakova; Marek Samec; Pavol Zubor; Anthony Zulli; Vanda Valentova; Taeg Kyu Kwon; Peter Solar; Martin Kello; Karol Kajo; Dietrich Busselberg; Martin Pec; Jan Danko
Journal:  EPMA J       Date:  2018-11-12       Impact factor: 6.543

Review 2.  Pregnancy-associated breast cancer: the risky status quo and new concepts of predictive medicine.

Authors:  Jiri Polivka; Irem Altun; Olga Golubnitschaja
Journal:  EPMA J       Date:  2018-02-08       Impact factor: 6.543

3.  Postmenopausal breast cancer: European challenge and innovative concepts.

Authors:  Ivica Smokovski; Milan Risteski; Jiri Polivka; Pavol Zubor; Katarzyna Konieczka; Vincenzo Costigliola; Olga Golubnitschaja
Journal:  EPMA J       Date:  2017-05-30       Impact factor: 6.543

Review 4.  Current approaches in the clinical management of pregnancy-associated breast cancer-pros and cons.

Authors:  Pavol Zubor; Peter Kubatka; Ivana Kapustova; Lence Miloseva; Zuzana Dankova; Alexandra Gondova; Tibor Bielik; Stefan Krivus; Jan Bujnak; Zuzana Laucekova; Christina Kehrer; Erik Kudela; Jan Danko
Journal:  EPMA J       Date:  2018-06-24       Impact factor: 6.543

Review 5.  Risks associated with the stroke predisposition at young age: facts and hypotheses in light of individualized predictive and preventive approach.

Authors:  Jiri Polivka; Jiri Polivka; Martin Pesta; Vladimir Rohan; Libuse Celedova; Smit Mahajani; Ondrej Topolcan; Olga Golubnitschaja
Journal:  EPMA J       Date:  2019-02-20       Impact factor: 6.543

6.  Vaginal dryness: individualised patient profiles, risks and mitigating measures.

Authors:  Vadym Goncharenko; Rostyslav Bubnov; Jiri Polivka; Pavol Zubor; Kamil Biringer; Tibor Bielik; Walther Kuhn; Olga Golubnitschaja
Journal:  EPMA J       Date:  2019-03-02       Impact factor: 6.543

7.  "Dry mouth" and "Flammer" syndromes-neglected risks in adolescents and new concepts by predictive, preventive and personalised approach.

Authors:  Analtoly Kunin; Jiri Polivka; Natalia Moiseeva; Olga Golubnitschaja
Journal:  EPMA J       Date:  2018-08-02       Impact factor: 6.543

Review 8.  Diseases potentially related to Flammer syndrome.

Authors:  Katarzyna Konieczka; Carl Erb
Journal:  EPMA J       Date:  2017-09-13       Impact factor: 6.543

Review 9.  The potential relationship between Flammer and Sjögren syndromes: the chime of dysfunction.

Authors:  Babak Baban; Olga Golubnitschaja
Journal:  EPMA J       Date:  2017-08-14       Impact factor: 6.543

10.  IDH1 mutation is associated with lower expression of VEGF but not microvessel formation in glioblastoma multiforme.

Authors:  Jiří Polívka; Martin Pešta; Pavel Pitule; Ondřej Hes; Luboš Holubec; Jiří Polívka; Tereza Kubíková; Zbyněk Tonar
Journal:  Oncotarget       Date:  2018-02-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.